<code id='072FC42BAE'></code><style id='072FC42BAE'></style>
    • <acronym id='072FC42BAE'></acronym>
      <center id='072FC42BAE'><center id='072FC42BAE'><tfoot id='072FC42BAE'></tfoot></center><abbr id='072FC42BAE'><dir id='072FC42BAE'><tfoot id='072FC42BAE'></tfoot><noframes id='072FC42BAE'>

    • <optgroup id='072FC42BAE'><strike id='072FC42BAE'><sup id='072FC42BAE'></sup></strike><code id='072FC42BAE'></code></optgroup>
        1. <b id='072FC42BAE'><label id='072FC42BAE'><select id='072FC42BAE'><dt id='072FC42BAE'><span id='072FC42BAE'></span></dt></select></label></b><u id='072FC42BAE'></u>
          <i id='072FC42BAE'><strike id='072FC42BAE'><tt id='072FC42BAE'><pre id='072FC42BAE'></pre></tt></strike></i>

          knowledge

          knowledge

          author:Wikipedia    Page View:488
          Alastair Grant/AP

          LONDON — AstraZeneca said Thursday it would purchase the French firm Amolyt Pharma in a deal worth up to $1 billion, picking up a rare disease drug in a pivotal trial.

          The acquisition includes an upfront payment of $800 million in cash, plus another $250 million if regulatory milestones are met. 

          advertisement

          AstraZeneca framed the deal for Amolyt, which has focused on treatments for rare endocrine diseases, as a boost for its own rare disease pipeline. 

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          United colonoscopy coverage change 'may cost lives,' doctors say
          United colonoscopy coverage change 'may cost lives,' doctors say

          AdobeWhengastroenterologistslearnedinMarchthatUnitedHealthcareplanstobarricademanycolonoscopiesbehin

          read more
          Big Tobacco's 'harm reduction': Is it for real, or a sham?
          Big Tobacco's 'harm reduction': Is it for real, or a sham?

          TOLGAAKMEN/AFP/GettyImagesThisyearcouldshapeuptobeahistoriconefortobaccocontrol—oroneinwhichBigTobac

          read more
          Sports medicine is finally prioritizing gender equality
          Sports medicine is finally prioritizing gender equality

          MollyFergusonforSTATWhencyclistAlisonTetrickjoinedthesport’sprofessionalranks,shereceivedtheperkstha

          read more

          Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

          AdobeRingTherapeutics,agenetherapystartuplaunchedbyFlagshipPioneering,haslaidoffjustunder20%ofitssta